Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Kopp Drug Selects Activant Eagle Solution

August 30, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

LIVERMORE, Calif., Aug. 30 /- Activant Solutions Inc., a leading provider of retail and distribution business management solutions, today announced that Kopp Drug Inc. has selected the Activant Eagle® software platform to be its business management and Point-of-Sale (POS) solution....

Millennium Laboratories Announces New Chief Operating Officer David Cohen

August 30, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Aug. 30 /- Millennium Laboratories , a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain, announced today the appointment of David Cohen to Chief Operating Officer. In his capacity as COO, Mr. Cohen is responsible for...

Covidien Completes Sale of Specialty Chemicals Business

August 30, 2010 3:33 am | by Covidien | News | Comments

DUBLIN, Aug 30, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Specialty Chemicals business to an affiliate of New Mountain Capital, L.L.C. for a cash purchase price...

Advertisement

Specialty Surgical Instrumentation Launches New Interactive Web Site

August 27, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., Aug. 27 /- Specialty Surgical Instrumentation, Inc. (SSI) a division of Symmetry Medical Inc. (NYSE: SMA ) and leading provider of surgical instruments and sterilization products, announced today the launch of a new interactive, e-commerce Web site at www.specsurg.com ....

ThermoGenesis Announces Reverse Stock Split Effective on NASDAQ Capital Market August 27, 2010

August 26, 2010 12:34 pm | by Bio-Medicine.Org | News | Comments

RANCHO CORDOVA, Calif., Aug. 26 /- ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier of innovative products and services that process and store adult stem cells, said it has filed a Certificate of Amendment to its Amended and Restated Certification of Incorporation to effect its...

meridianEMR, Inc. Honored by Inc. 5000 for Second Year in a Row as One of the Fastest-Growing Private Companies

August 26, 2010 12:34 pm | by Bio-Medicine.Org | News | Comments

LIVINGSTON, N.J., Aug. 26 /- meridianEMR, Inc., a leading provider of electronic medical records systems, electronic prescribing and advanced healthcare analytics, announced today that Inc. Magazine ranked the company No. 1717 in its annual ranking of the 5,000 fastest-growing...

Deloitte Issue Brief: Mobile Personal Health Records May Offer Consumers Key to Technology-Enabled Self-Care

August 26, 2010 12:34 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON, Aug. 26 /- The convergence of personal health records and mobile communication devices may provide the mechanism to engage consumers to use technology to enhance self-care, taking cost out of the health care system, according to a new Deloitte Issue Brief released today by the...

Society of Interventional Radiology Supports Research for New M.S. Treatments

August 26, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

FAIRFAX, Va., Aug. 26 /PRNewswire-USNewswire/ -- Recognizing that venous interventions may potentially play an important role in treating some patients who suffer from multiple sclerosis -- an incurable, disabling disease -- the Society of Interventional Radiology has issued a position...

Advertisement

ViewRay Secures Series C Financing

August 25, 2010 1:37 pm | by Bio-Medicine.Org | News | Comments

CLEVELAND, Aug. 25 /- ViewRay™, Inc., a privately held medical device company, has secured $20 million in Series C financing led by new investor Siemens Venture Capital (SVC) GmbH and joined by existing investors Aisling Capital, Fidelity Biosciences, Kearny Venture Partners and...

Ambry Genetics Announces the Addition of Illumina HiSeq 2000 and First 510(K) Approved BeadXpress® to Its Sequencing and Genotyping Capabilities

August 25, 2010 1:37 pm | by Bio-Medicine.Org | News | Comments

ALISO VIEJO, Calif., Aug. 25 /- Ambry Genetics, a global leader in genomic services, announced today that it has acquired the Illumina HiSeq 2000 Next Generation Sequencing System as well as received the first 510(K) approved Illumina BeadXpress Genotyping System. Ambry Genetics has been...

Pharmacovigilance Breakthrough: Henry Ford Health System Partners with Rexam and Med Time Technology to Remind Patients to Take Prescription Medication "As Prescribed" to redu...

August 25, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

DEARBORN, Mich., Aug. 25 /- A leader in healthcare, Henry Ford Health System will introduce at its hospitals and pharmacies "The Pill Timer," representing a "breakthrough" designed to improve treatment outcomes and reduce adverse drug events often resulting in costly hospital admissions...

Reportlinker Adds Pharmaceutical M & A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions

August 25, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 25 /- Reportlinker.com announces that a new market research report is available in its catalogue: Pharmaceutical M&A in the Asia-Pacific Region – India and China drive regional activity but Japan still dominates high value transactions...

PharMEDium Elects William R. Spalding to Board of Directors

August 25, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill., Aug. 25 /- David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation announced the election of William R. Spalding to the company's Board of Directors. Spalding is Co-founder and Principal of The Crawford Spalding Group, an advisory and management services...

Advertisement

Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference

August 25, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and... -- SHENZHEN, China, Aug. 25 /PRNewswire-Asia-FirstCall/ --

Kewaunee Scientific Corporation Declares Quarterly Dividend

August 25, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

STATESVILLE, N.C., Aug. 25 /- Kewaunee Scientific Corporation (Nasdaq: KEQU ) announced today that its Board of Directors declared a quarterly cash dividend of ten cents per outstanding share, payable on September 23, 2010 to stockholders of record at the close of business on September 9,...

Veteran Affairs Announces That Redsense Alarm Will be Mandatory on Patients by November 1, 2010

August 25, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

Veteran Affairs Announces That Redsense Alarm Will be Mandatory on... -- HALMSTAD, Sweden and CHICAGO, August 25, 2010 /-

Reportlinker Adds Portable and Transport Ventilator Market Shares, Strategies, and Forecasts, Worldwide, 2010 to 2016

August 25, 2010 7:31 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 25 /- Reportlinker.com announces that a new market research report is available in its catalogue: Portable and Transport Ventilator Market Shares, Strategies, and Forecasts, Worldwide, 2010 to 2016...

Reportlinker Adds Clinical Laboratory Testing Volume 1: Reagents and Instruments

August 25, 2010 7:31 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 25 /- Reportlinker.com announces that a new market research report is available in its catalogue: Clinical Laboratory Testing Volume 1: Reagents and Instruments http://www.reportlinker.com/p0284247/Clinical-Laboratory-Testing-Volume-1-Reagents-and-Instruments.html Clinical...

Embryonic Stem Cell Research in the Toilet, According to Arthritis Treatment Center

August 25, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

FREDERICK, Md., Aug. 25 /- The recent ruling by federal judge Royce C. Lamberth halting embryonic stem cell research may present a hurdle for some disease research but not necessarily for arthritis.  A key note presentation, entitled " Guided Mesenchymal Stem Cell Layering Technique...

Jennerex Appoints Lara Longpre to Chief Operating Officer

August 25, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO, Aug. 25 /- Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced the appointment of Lara Longpre to the position of chief operating officer. Ms. Longpre will be responsible for the development of the company's lead product, JX-594, as well as...

KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Company's ADHD Prodrug Technology

August 25, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

NORTH LIBERTY, Iowa, Aug. 25 /- KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the...

Comfort Medical Supply, LLC Ranks No. 461 on the 2010 Inc. 500 with Three-Year Sales Growth of 649%

August 24, 2010 12:38 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 24 /- Inc. magazine today ranked Comfort Medical Supply, LLC of Ormond Beach, FL NO. 461 on its 28th annual Inc. 500, an exclusive ranking of the nation's fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the...

FDA's New Safety Controls for LABA-Containing Drugs Will Impact Prescribing of Single-Agent ICS and LABA/ICS Combination Therapies for the Treatment of Asthma

August 24, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., Aug. 24 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that some surveyed physicians indicate that they will decrease their overall prescribing of long-acting beta2 agonists (LABA)/inhaled...

Pfenex Inc. Establishes Reagent Protein Distribution Agreement With Cedarlane Corporation

August 24, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Aug. 24 /- Pfenex Inc. and Cedarlane today announced that they have entered into a non-exclusive distribution agreement. Cedarlane will market and distribute high value reagent proteins produced by Pfenex to researchers in Canada and the United States. Among the products...

The SCOOTER Store Partners With Branding Leader

August 24, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

NEW BRAUNFELS, Texas, Aug. 24 /- The SCOOTER Store announced today it has selected an integrated Omnicom team to join its network of agency partners. The company is revamping its roster of agencies to include a new team that provides a deeper understanding of the U.S. healthcare market...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading